{"id":"jitongning-tablets","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL942","moleculeType":"Small molecule","molecularWeight":"361.40"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Jitongning is a traditional Chinese medicine formulation designed to address pain and circulatory dysfunction. The tablet formulation combines herbal ingredients intended to invigorate blood circulation, remove blood stasis, and alleviate pain associated with various conditions. The exact molecular mechanisms are not well-characterized in Western pharmacological terms.","oneSentence":"Jitongning tablets work by improving blood circulation and reducing pain through traditional Chinese medicine principles, likely by promoting qi and blood flow.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:17:36.138Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pain relief and circulatory dysfunction (specific indications in Phase 3 development unclear)"}]},"trialDetails":[{"nctId":"NCT06000956","phase":"PHASE3","title":"A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo","status":"RECRUITING","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2023-09-11","conditions":"Ankylosing Spondylitis","enrollment":408},{"nctId":"NCT03932019","phase":"PHASE2","title":"Study of Jitongning Tablet to Treat Spondyloarthritis","status":"COMPLETED","sponsor":"Tasly Pharmaceutical Group Co., Ltd","startDate":"2019-06-11","conditions":"Spondyloarthritis","enrollment":238}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Jitongning tablets","genericName":"Jitongning tablets","companyName":"Tasly Pharmaceutical Group Co., Ltd","companyId":"tasly-pharmaceutical-group-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Jitongning tablets work by improving blood circulation and reducing pain through traditional Chinese medicine principles, likely by promoting qi and blood flow. Used for Pain relief and circulatory dysfunction (specific indications in Phase 3 development unclear).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}